|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02877 SHINEWAY PHARM
Nominal 
8.220 +0.040 (+0.489%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 963,135 | 932,635 | 1,109,676 | 703,150 |
| Net Cash from / (used in) Investing Activities | -- | (272,110) | (49,540) | (45,420) | 395,011 |
| Net Cash from / (used in) Financing Activities | -- | (392,475) | (26,738) | (250,038) | (828,935) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 298,550 | 856,357 | 814,218 | 269,226 |
| Cash & Cash Equivalents at beginning of period | -- | 5,888,776 | 5,026,265 | 4,205,722 | 3,943,010 |
| Effect of Foreign Exchange Rate Changes | -- | (47,173) | 6,154 | 6,325 | (6,514) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 6,140,153 | 5,888,776 | 5,026,265 | 4,205,722 |
| Remarks: | Real time quote last updated: 12/12/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 614,663 |
| %Change | -1.886% |
| EPS / (LPS) | RMB 0.810 |
| NBV Per Share (¥) | RMB 9.443 |